FindTrial
Sign In

The application of MRI in predicting therapeutic effect and prognosis of chemoradiotherapy for esophageal cancer

The application of MRI in predicting therapeutic effect and prognosis of chemoradiotherapy for esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PNC-16009484
Enrollment
Unknown
Registered
2016-10-18
Start date
2016-10-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal carcinoma

Interventions

Case series:chemoradiotherapy

Sponsors

The fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: ESCC was confirmed by tumor tissue pathology. The Karnofsky per- formance status (KPS) was = 70. No distant metastasis was found under routine medical care. The patient was able to have MRDWI exams before and after CRT, and have signed an informed consent form.

Exclusion criteria

Exclusion criteria: TNM ?

Design outcomes

Primary

MeasureTime frame
OS;TE;—

Countries

China

Contacts

Public ContactZhang Andu

Radiation Oncology of The Fourth Hospital of Hebei Medical University

zhangandu860520@163.com+86 13803215410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026